Document Detail


Predictors of hemostatic failure after adrenaline injection in patients with peptic ulcers with non-bleeding visible vessel.
MedLine Citation:
PMID:  15223687     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Non-bleeding visible vessel (NBVV) in patients with bleeding peptic ulcer is associated with a high risk of rebleeding. The aim of this study was to define factors associated with failure of endoscopic hemostasis and rebleeding in patients with NBVV. METHODS: Clinical and endoscopic parameters related to failure of endoscopic hemostasis with adrenaline in 191 bleeding peptic ulcer patients with NBVV were evaluated. RESULTS: Endoscopic hemostasis was permanently successful in 154 patients (80.6%). Emergency surgical hemostasis for rebleeding was required in 37 patients (19.4%). Univariate analysis showed that therapeutic failure was significantly related to the presence of shock on admission (P=0.003), posterior duodenal ulcers (P=0.001), peptic ulcer history (P=0.001), previous peptic ulcer bleeding (P=0.002), or lack of history of non-steroidal anti-inflammatory drugs consumption, when compared to use of such drugs (P=0.04). Patients where therapy failed had lower hemoglobin levels at admission (7.8+/-1.9 g/dL versus 10+/-2.4 g/dL, P=0.005). In a multivariate analysis low hemoglobin (P<0.001) as well as history of previous peptic ulcer bleeding (P=0.002) and posterior duodenal ulcers (P=0.001) were negative predictors. Using the mean value of hemoglobin as the cut-off point, it is noteworthy that only 2 out of 81 patients (2.5%) who had none of these predictive factors required emergency surgical hemostasis, whereas 34 out of 110 patients (30.9%) with at least one predictive factor required emergency surgery. CONCLUSION: It is possible, by employing specific characteristics, to define a subgroup of high-risk patients for rebleeding in patients with NBVV despite therapeutic endoscopy and thus candidates for a complementary endoscopic method of hemostasis or emergency surgical intervention.
Authors:
K C Thomopoulos; G J Theocharis; K A Vagenas; D D Danikas; C E Vagianos; V N Nikolopoulou
Related Documents :
234267 - Failure of secretin release in patients with duodenal ulcer.
8449127 - Is aggressive management of perianal ulcers in homosexual hiv-seropositive men justified?
1247157 - Human gastrin response to secretin after vagotomy.
310287 - Prompt endoscopic diagnosis of upper gastrointestinal hemorrhage: its value for specifi...
17283037 - Haplotype analysis of the estrogen receptor 1 gene in male genital and reproductive abn...
6218077 - Study of helper and suppressor t-cells in cystic fibrosis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  39     ISSN:  0036-5521     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-06-29     Completed Date:  2004-11-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  600-4     Citation Subset:  IM    
Affiliation:
Dept. of Internal Medicine, Division of Gastroenterology, Rion University Hospital, Patras, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Epinephrine / administration & dosage*
Female
Hemostasis, Endoscopic*
Humans
Injections, Intralesional
Male
Middle Aged
Peptic Ulcer Hemorrhage / pathology,  therapy*
Recurrence
Risk Factors
Treatment Failure
Vasoconstrictor Agents / administration & dosage*
Chemical
Reg. No./Substance:
0/Vasoconstrictor Agents; 51-43-4/Epinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combined liver vein and spleen pulp pressure measurements in patients with portal or splenic vein th...
Next Document:  Yersinia infection mimicking recurrence of gastrointestinal stromal tumor.